Exploiting the curative potential of adoptive T‐cell therapy for cancer

Hinrichs, Christian S., Rosenberg, Steven A.·2014·Immunological Reviews

DOI 10.1111/imr.12132

Cited by (465)

Items 101–200 of 465

Engineered cell entry links receptor biology with single-cell genomics
Bingfei Yu, Quanming Shi, Julia A. Belk, Kathryn E. Yost, Kevin R. Parker, Rui Li, Betty B. Liu, Huang Huang, Daniel Lingwood, William James Greenleaf et al. · 2022 · Cell
Multifunctional STING‐Activating Mn3O4@Au‐dsDNA/DOX Nanoparticle for Antitumor Immunotherapy
Min Zhou, Xiaoyu Wang, Shichao Lin, Yuan Cheng, Sheng Zhao, Junshu Lin, Zhuoyao Fang, Zhangping Lou, Li Qin, Hui Wei · 2020 · Advanced Healthcare Materials
Synthesis and Evaluation of a Macrocyclic Actinium‐225 Chelator, Quality Control and In Vivo Evaluation of 225Ac‐crown‐αMSH Peptide
Hua Yang, Chengcheng Zhang, Zheliang Yuan, Cristina Rodríguez‐Rodríguez, Andrew K. H. Robertson, Valery Radchenko, Randy Perron, Denise Gendron, Patrick W. Causey, Feng Gao et al. · 2020 · Chemistry - A European Journal
EZH2 Inhibition: A Promising Strategy to Prevent Cancer Immune Editing
Ning Kang, Mark Eccleston, Pier‐Luc Clermont, Maryam Latarani, David Kingsley Male, Yuzhuo Z. Wang, Francesco Crea · 2020 · Epigenomics
T-cell-engaging antibodies for the treatment of solid tumors: challenges and opportunities
Patrick A. Baeuerle, Holger Wesche · 2022 · Current Opinion in Oncology
Trial Watch: Adoptively transferred cells for anticancer immunotherapy
Carole Fournier, François Martin, Laurence Zitvogel, Guido Kroemer, Lorenzo Galluzzi, Lionel Apétoh · 2017 · OncoImmunology
CRISPR–Cas9 a boon or bane: the bumpy road ahead to cancer therapeutics
Debarati Ghosh, Prabhadevi Venkataramani, Saikat Nandi, Sonali Bhattacharjee · 2019 · Cancer Cell International
Breaking Free of Control: How Conventional T Cells Overcome Regulatory T Cell Suppression
Emily Mercadante, Ulrike M. Lorenz · 2016 · Frontiers in Immunology
Chimeric antigen receptor–engineered T cells as oncolytic virus carriers
Heather VanSeggelen, Daniela G.M. Tantalo, Arya Afsahi, Joanne A. Hammill, Jonathan L. Bramson · 2015 · Molecular Therapy — Oncolytics
Engineering Chimeric Antigen Receptor T-Cells for Racing in Solid Tumors: Don’t Forget the Fuel
Melita B. Irving, Romain Vuillefroy de Silly, Kirsten B. J. Scholten, Nahzli Dilek, George Coukos · 2017 · Frontiers in Immunology
Tumor-infiltrating lymphocytes predict cutaneous melanoma survival
Cristina Fortes, Simona Mastroeni, Thomas J. Mannooranparampil, Francesca Passarelli, Alba Zappalà, Giorgio Annessi, Claudia Marino, Alessio Caggiati, Nicoletta Russo, Paola Michelozzi · 2015 · Melanoma Research
T-cell Responses in the Microenvironment of Primary Renal Cell Carcinoma—Implications for Adoptive Cell Therapy
Rikke Sick Andersen, Marie Christine Wulff Westergaard, Julie Westerlin Kjeldsen, Anja Müller, Natasja Wulff Pedersen, Sine Reker Hadrup, Özcan Met, Barbara Seliger, Bjarne Kromann‐Andersen, Thomas Hasselager et al. · 2018 · Cancer Immunology Research
Impact of exercise on the immune system and outcomes in hematologic malignancies
Andrea Phillips Sitlinger, Danielle M. Brander, David B. Bartlett · 2020 · Blood Advances
Cell-Intrinsic Barriers of T Cell-Based Immunotherapy
Hazem E. Ghoneim, Anthony Elston Zamora, Paul Glyndwr Thomas, Ben Youngblood · 2016 · Trends in Molecular Medicine
Affinity-enhanced T-cell receptors for adoptive T-cell therapy targeting MAGE-A10: strategy for selection of an optimal candidate
E.C. Border, Joseph P. Sanderson, Thomas Weissensteiner, Andrew B. Gerry, Nicholas J. Pumphrey · 2018 · OncoImmunology
Progress in the cryoablation and cryoimmunotherapy for tumor
Zenan Chen, Liangliang Meng, Jing Zhang, Xiao Zhang · 2023 · Frontiers in Immunology
Biology of Cancer-Testis Antigens and Their Therapeutic Implications in Cancer
Dawn Sijin Nin, Lih‐Wen Deng · 2023 · Cells
Antitumor activity of total flavonoids from Tetrastigma hemsleyanum Diels et Gilg is associated with the inhibition of regulatory T cells in mice
Juhua Zhou, Wanrong Hao, Xiaoyang Lin, Daping Fan, Zhengquan Feng · 2014 · OncoTargets and Therapy
Cancer Vaccine Immunotherapy with RNA-Loaded Liposomes
Elias Joseph Sayour, Héctor R. Méndez‐Gómez, Duane A. Mitchell · 2018 · International Journal of Molecular Sciences
Bio‐Orthogonal T Cell Targeting Strategy for Robustly Enhancing Cytotoxicity against Tumor Cells
Wenjun Li, Hong Pan, Huamei He, Xiaoqing Meng, Qian Ren, Ping Gong, Xin Jiang, Zhenguo Liang, Lanlan Liu, Mingbin Zheng et al. · 2018 · Small
TCRmodel: high resolution modeling of T cell receptors from sequence
Ragul Gowthaman, Brian G. Pierce · 2018 · Nucleic Acids Research
Ovarian Cancer Immunotherapy: Preclinical Models and Emerging Therapeutics
Curtis W. McCloskey, Galaxia M. Rodriguez, Kristianne J.C. Galpin, Barbara C. Vanderhyden · 2018 · Cancers
Alkylating Agent Melphalan Augments the Efficacy of Adoptive Immunotherapy Using Tumor-Specific CD4+ T Cells
Xiaoyun Lu, Zhi‐Chun Ding, Yang Cao, Chufeng Liu, Tsadik Ghebreamlak Habtetsion, Miao Yu, Henrique de Paula Lemos, Huda Salman, Hongyan Xu, Andrew L. Mellor et al. · 2015 · The Journal of Immunology
Recent Successes and Future Directions in Immunotherapy of Cutaneous Melanoma
Hassan Sadozai, Thomas Gruber, Robert E. Hunger, Mirjam Schenk · 2017 · Frontiers in Immunology
Beyond CAR T Cells: Other Cell-Based Immunotherapeutic Strategies Against Cancer
Shabnum Patel, Rachel A. Burga, Allison B. Powell, Elizabeth A. Chorvinsky, Nia Hoq, Sarah McCormack, Stacey N. Van Pelt, Patrick J. Hanley, Carolina Colli Cruz · 2019 · Frontiers in Oncology
Stable, Nonviral Expression of Mutated Tumor Neoantigen-specific T-cell Receptors Using the Sleeping Beauty Transposon/Transposase System
Drew C. Deniger, Anna Pasetto, Eric Tran, Maria R. Parkhurst, Cyrille J. Cohen, Paul F. Robbins, Laurence J.N. Cooper, Steven A. Rosenberg · 2016 · Molecular Therapy
Safety and clinical activity of PD-L1 blockade in patients with aggressive recurrent respiratory papillomatosis
Clint Tanner Allen, Sunmin Lee, Scott Michael Norberg, Damián Kovalovsky, Ye Hong, Paúl E. Clavijo, Siwen Hu‐Lieskovan, Richard Schlegel, Jeffrey Schlom, Julius Strauss et al. · 2019 · Journal for ImmunoTherapy of Cancer
Effective screening of T cells recognizing neoantigens and construction of T-cell receptor-engineered T cells
Taigo Kato, Tatsuo Matsuda, Yuji Ikeda, Jae-Hyun Park, Matthias Leisegang, Sachiko Yoshimura, Tetsuro Hikichi, Makiko Harada, Makda Getachew Zewde, Sho Sato et al. · 2018 · Oncotarget
Novel Immunotherapies for Osteosarcoma
Yubao Lu, Jiahe Zhang, Yutong Chen, Yuchen Kang, Zhipeng Liao, Yuanqi He, Cangyu Zhang · 2022 · Frontiers in Oncology
Harnessing neoantigen specific CD4 T cells for cancer immunotherapy
Spencer E. Brightman, Martin S. Naradikian, Aaron M. Miller, Stephen Philip Schoenberger · 2020 · Journal of Leukocyte Biology
Preclinical Melanoma Imaging with 68Ga-Labeled α-Melanocyte-Stimulating Hormone Derivatives Using PET
Chengcheng Zhang, Zhengxing Zhang, Kuo‐Shyan Lin, Jinhe Pan, Iulia Dude, Navjit Hundal-Jabal, Nadine Colpo, François Bénard · 2017 · Theranostics
Retracted: Applications and advances of CRISPR-Cas9 in cancer immunotherapy
Anliang Xia, Qifeng He, Jincheng Wang, Jing Zhu, Yeqin Sha, Beicheng Sun, Xiaojie Lu · 2018 · Journal of Medical Genetics · Retracted
The proteasome immunosubunits, PA28 and ER‐aminopeptidase 1 protect melanoma cells from efficient MART‐126‐35‐specific T‐cell recognition
Martin Keller, Frédéric Ebstein, Elke Bürger, Kathrin Textoris‐Taube, Xenia Gorny, Sabrina Urban, Fang Zhao, Tanja Dannenberg, Antje Sucker, Christin Keller et al. · 2015 · European Journal of Immunology
Myeloid-derived suppressor cell impact on endogenous and adoptively transferred T cells
Ainhoa Arina, Vincenzo Bronte · 2015 · Current Opinion in Immunology
Checkpoint immunotherapy in head and neck cancers
Paul Zolkind, Ravindra Uppaluri · 2017 · Cancer and Metastasis Reviews
Immunotherapy for Dogs: Running Behind Humans
Hans Klingemann · 2018 · Frontiers in Immunology
Microglia and macrophages in glioblastoma: landscapes and treatment directions
Georgios Solomou, Adam M. H. Young, Harry J. C. J. Bulstrode · 2024 · Molecular Oncology
A single infusion of engineered long-lived and multifunctional T cells confers durable remission of asthma in mice
Gang Jin, Yanyan Liu, Lixia Wang, Zihao He, Xiaocui Zhao, Yuying Ma, Yuting Jia, Zhuoyang Li, Na Yin, Min Peng · 2024 · Nature Immunology
Enhancing T cell therapy by overcoming the immunosuppressive tumor microenvironment
Ainhoa Arina, Leticia P. Corrales, Vincenzo Bronte · 2016 · Seminars in Immunology
Natural killer cells facilitate PRAME-specific T-cell reactivity against neuroblastoma
Lotte Spel, Jaap Jan Boelens, Dirk M. van der Steen, Nina J.G. Blokland, Max Maria van Noesel, Jan J. Molenaar, Mirjam H.M. Heemskerk, Marianne L. Boes, Stefan Nierkens · 2015 · Oncotarget
Targeting the undruggable: immunotherapy meets personalized oncology in the genomic era
Spencer D. Martin, George Coukos, Robert A. Holt, Brad H. Nelson · 2015 · Annals of Oncology
Enhanced efficacy and limited systemic cytokine exposure with membrane-anchored interleukin-12 T-cell therapy in murine tumor models
Ling Zhang, John S Davies, Carylinda Serna, Zhiya Yu, Nicholas P. Restifo, Steven A. Rosenberg, Richard A. Morgan, Christian S. Hinrichs · 2020 · Journal for ImmunoTherapy of Cancer
The Advances and Challenges of NK Cell-Based Cancer Immunotherapy
Synat Kang, Xuefeng Gao, Li Zhang, Erna Yang, Yonghui Li, Li Yu · 2021 · Current Oncology
On the way to find a cure: Purging latent HIV-1 reservoirs
Christian Schwartz, Sophie Bouchat, Céline Marban, Virginie Gautier, Carine M. Van Lint, Olivier Rohr, Valentin Le Douce · 2017 · Biochemical Pharmacology
The Cross Talk between Cancer Stem Cells/Cancer Initiating Cells and Tumor Microenvironment: The Missing Piece of the Puzzle for the Efficient Targeting of these Cells with Immunotherapy
Shilpa Ravindran, Saad Rasool, Cristina Maccalli · 2019 · Cancer Microenvironment
Genetic Engineering and Enrichment of Human NK Cells for CAR-Enhanced Immunotherapy of Hematological Malignancies
Maren Soldierer, Arthur Bister, Corinna Haist, Aniththa Thivakaran, Sevgi Can Cengiz, Stephanie Sendker, Nina Bartels, Antonia Thomitzek, Denise Smorra, Maryam Hejazi et al. · 2022 · Frontiers in Immunology
Oncolytic Virus Immunotherapy for Melanoma
Neal D. Dharmadhikari, Janice M. Mehnert, Howard L. Kaufman · 2015 · Current Treatment Options in Oncology
Human Regulatory T Cells From Umbilical Cord Blood Display Increased Repertoire Diversity and Lineage Stability Relative to Adult Peripheral Blood
Keshav Motwani, Leeana D. Peters, Willem H. Vliegen, Ahmed G Elsayed, Howard R. Seay, M. Cecilia López, Henry V. Baker, Amanda L. Posgai, Maigan Brusko, Daniel J. Perry et al. · 2020 · Frontiers in Immunology
EEG findings in CAR T-cell-associated neurotoxicity: Clinical and radiological correlations
Isabelle Beuchat, Husain H. Danish, Daniel B. Rubin, Caron Alyce Jacobson, Matthew S. Robertson, Henrikas Vaitkevicius, Jong Woo Lee · 2021 · Neuro-Oncology
Overcoming Tumor-Mediated Immunosuppression
Hans Schlößer, Sebastian Theurich, Alexander Shimabukuro‐Vornhagen, Udo Holtick, Dirk Ludger Stippel, Michael von Bergwelt‐Baildon · 2014 · Immunotherapy
CD8+ T Cell-Independent Immune-Mediated Mechanisms of Anti-Tumor Activity
G. Elizabeth Pluhar, Christopher A. Pennell, Michael R. Olin · 2015 · Critical Reviews in Immunology
CRISPR therapeutic tools for complex genetic disorders and cancer (Review)
Stella Baliou, Maria Adamaki, Anthony M. Kyriakopoulos, Demetrios A. Spandidos, Mihalis I. Panayiotidis, Ioannis Christodoulou, Vassilis C. Zoumpourlis · 2018 · International Journal of Oncology
Engineering T cells for cancer: our synthetic future
Robert H. Vonderheide, Carl H. June · 2013 · Immunological Reviews
Potential applications of nanoparticles in cancer immunotherapy
Yimei Jia, Abdelwahab Omri, Lakshmi Krishnan, Michael J. McCluskie · 2016 · Human Vaccines & Immunotherapeutics
The New Era of Cancer Immunotherapy
Danny N. Khalil, Sadna Budhu, Billel Gasmi, Roberta Zappasodi, Daniel Hirschhorn-Cymerman, Tamar Plitt, Olivier De Henau, Dmitriy Zamarin, Rikke Holmgaard, Judith T. Murphy et al. · 2015 · Advances in cancer research
Checkpoint Inhibitors and Their Application in Breast Cancer
Davide Bedognetti, Cristina Maccalli, Salha B.J. Al Bader, Francesco Maria Marincola, Barbara Seliger · 2016 · Breast Care
Lentivirus-induced ‘Smart’ dendritic cells: Pharmacodynamics and GMP-compliant production for immunotherapy against TRP2-positive melanoma
Bala Sai Sundarasetty, Lucas Chan, D Darling, G Giunti, Farzin Farzaneh, Florian Schenck, Sonja Naundorf, Klaus Kuehlcke, Eliana Ruggiero, Manfred Schmidt et al. · 2015 · Gene Therapy
SLFN11 can sensitize tumor cells towards IFN-γ-mediated T cell killing
Riccardo Mezzadra, Marjolein J. W. de Bruijn, Lucas T. Jae, Raquel Gomez, Anja M. Duursma, Ferenc A. Scheeren, Thijn R. Brummelkamp, Ton N. Schumacher · 2019 · PLoS ONE
Perspectives on immunotherapy via oncolytic viruses
Alberto Reale, Adriana Vitiello, Valeria Conciatori, Cristina Parolin, Arianna Calistri, Giorgio Palù · 2019 · Infectious Agents and Cancer
The Diagnostic, Prognostic, and Therapeutic Potential of Adaptive Immune Receptor Repertoire Profiling in Cancer
Lindsay Grey Cowell · 2019 · Cancer Research
Immunotherapy Bridge 2016 and Melanoma Bridge 2016: meeting abstracts
Vera Hirsh, Sandro Pignata, Melissa Bersanelli, Letizia Gnetti, Cinzia Azzoni, Lorena Bottarelli, Donatello Gasparro, Francesco Leonardi, Enrico Maria Silini, Sebastiano Buti et al. · 2017 · Journal of Translational Medicine
CRISPR-Cas System: The Current and Emerging Translational Landscape
Narendranath Bhokisham, Ethan Laudermilch, Lindsay L. Traeger, Tonya D. Bonilla, Mercedes Ruíz-Estévez, Jordan R. Becker · 2023 · Cells
Toxicities, intensive care management, and outcome of chimeric antigen receptor T cells in adults: an update
Mathieu Bellal, Jolan Malherbe, Gandhi Laurent Damaj, Damien du Cheyron · 2024 · Critical Care
Sustained Complete Response to CTLA-4 Blockade in a Patient with Metastatic, Castration-Resistant Prostate Cancer
Julie Nicole Graff, Sachin Puri, Carlo Bruno Bifulco, Bernard A. Fox, Tomasz M. Beer · 2014 · Cancer Immunology Research
The Interplay between T Cells and Cancer: The Basis of Immunotherapy
Christina Chen, Xin Liu, Che‐Yu Chang, Helen Y. Wang, Rong‐Fu Wang · 2023 · Genes
New insights into tumor immunity revealed by the unique genetic and genomic aspects of ovarian cancer
Brad H. Nelson · 2015 · Current Opinion in Immunology
Malignant melanoma—The cradle of anti-neoplastic immunotherapy
Kristian Michael Koller, Wenge Wang, Todd D. Schell, Eugene M. Cozza, Kathleen M. Kokolus, Rogerio Izar Neves, Heath B. Mackley, Colette R. Pameijer, Anna Mary Leung, Bryan E. Anderson et al. · 2016 · Critical Reviews in Oncology/Hematology
Driving CARs on the Highway to Solid Cancer: Some Considerations on the Adoptive Therapy with CAR T Cells
Hinrich Abken · 2017 · Human Gene Therapy
Cytokine chemokine network in tumor microenvironment: Impact on CSC properties and therapeutic applications
Mushtaq Ahmad Nengroo, Ayushi Verma, Dipak B. Datta · 2022 · Cytokine
A novel T cell receptor single-chain signaling complex mediates antigen-specific T cell activity and tumor control
Jennifer D. Stone, Daniel T. Harris, Carolina M. Soto, Adam S. Chervin, David Henry Aggen, Edward J. Roy, David M. Kranz · 2014 · Cancer Immunology Immunotherapy
T-cell therapies for HIV: Preclinical successes and current clinical strategies
Shabnum Patel, Richard Brad Jones, Douglas F. Nixon, Catherine M. Bollard · 2016 · Cytotherapy
Emergence of immunotherapy as a novel way to treat hepatocellular carcinoma
Naofumi Mukaida, Yasunari Nakamoto · 2018 · World Journal of Gastroenterology
N-cadherin inhibitor creates a microenvironment that protect TILs from immune checkpoints and Treg cells
Yi Sun, Jun Jing, Huan Xu, Lingfan Xu, Hailiang Hu, Cai Tang, Shengzhuo Liu, Qiang Wei, Ruiqi Duan, Ju Guo et al. · 2021 · Journal for ImmunoTherapy of Cancer
Human tumor infiltrating lymphocytes cooperatively regulate prostate tumor growth in a humanized mouse model
Michael D. Roth, Airi Harui · 2015 · Journal for ImmunoTherapy of Cancer
Targeted therapies in gynaecological cancers
Shanthini Mary Crusz, Rowan E. Miller · 2019 · Histopathology
Targeting T Cell Activation in Immuno-Oncology
Samuel David Saibil, Pamela S. Ohashi · 2020 · Current Oncology
Photosensitisation facilitates cross-priming of adjuvant-free protein vaccines and stimulation of tumour-suppressing CD8 T cells
Monika Håkerud, Pål Kristian Selbo, Ying Waeckerle‐Men, Emmanuel Contassot, Piotr Dziunycz, Thomas M. Kündig, Anders Høgset, Pål Johansen · 2014 · Journal of Controlled Release
Development of a multifunctional envelope-type nano device and its application to nanomedicine
Yusuke Sato, Takashi Nakamura, Yuma Yamada, Hideyoshi Harashima · 2016 · Journal of Controlled Release
Genetically stable poliovirus vectors activate dendritic cells and prime antitumor CD8 T cell immunity
Mubeen Mosaheb, Elena Yu Dobrikova, Michael C. Brown, Yuanfan Yang, Jana M. Cable, Hideho Okada, Smita K. Nair, Darell D. Bigner, David M. Ashley, Matthias Gromeier · 2020 · Nature Communications
Clinical cancer research: the past, present and the future
Vincent T. DeVita, Alexander M.M. Eggermont, Samuel Hellmän, David James Kerr · 2014 · Nature Reviews Clinical Oncology
Immunomodulation in cancer
Joost P. Hegmans, Joachim G.J.V. Aerts · 2014 · Current Opinion in Pharmacology
SITC cancer immunotherapy resource document: a compass in the land of biomarker discovery
Siwen Hu‐Lieskovan, Srabani Bhaumik, Kavita M. Dhodapkar, Jean‐Charles Grivel, Sumati V. Gupta, Brent Allen Hanks, Sylvia Janetzki, Thomas O. Kleen, Yoshinobu Koguchi, Amanda W. Lund et al. · 2020 · Journal for ImmunoTherapy of Cancer
Emerging immunotherapies for bladder cancer
Joseph W. Kim, Yusuke Tomita, Jane B. Trepel, Andrea Borghese Apolo · 2015 · Current Opinion in Oncology
The potential of nanoparticle vaccines as a treatment for cancer
David Benjamin Urbanavicius, Tara Alvarez, Georgina K. Such, Angus P. R. Johnston, Justine D. Mintern · 2018 · Molecular Immunology
Adoptive T Cell Therapy with IL-12–Preconditioned Low-Avidity T Cells Prevents Exhaustion and Results in Enhanced T Cell Activation, Enhanced Tumor Clearance, and Decreased Risk for Autoimmunity
Christopher Tucker, Jason S. Mitchell, Tijana Martinov, Brandon J. Burbach, Lalit K. Beura, Joseph C Wilson, Alexander J. Dwyer, Lovejot M. Singh, Matthew F. Mescher, Brian T. Fife · 2020 · The Journal of Immunology
Interleukin‐33 is a Novel Immunosuppressor that Protects Cancer Cells from TIL Killing by a Macrophage‐Mediated Shedding Mechanism
Jing Wu, Ziqing Chen, Stina Linnea Wickström, Juan Gao, Xingkang He, Jing Xu, Jieyu Wu, Qiqiao Du, Muyi Yang, Yi Chen et al. · 2021 · Advanced Science
The challenges of solid tumor for designer CAR-T therapies: a 25-year perspective
Richard Paul Junghans · 2017 · Cancer Gene Therapy
The Effectiveness of Various Chemotherapeutic Agents in Cancer Treatment
J. Kashifa Fathima, VALLURI ANITHA LAVANYA, Shazia Jamal, Neesar Ahmed · 2022 · Current Pharmacology Reports
Lipid nanoparticles: a promising tool for nucleic acid delivery in cancer immunotherapy
Tasneem Abaza, Eman Mohamed, Mohamed Y. Zaky · 2025 · Medical Oncology
Epigenetic Strategies to Boost Cancer Immunotherapies
María J. Barrero · 2017 · International Journal of Molecular Sciences
Parking CAR T Cells in Tumours: Oncolytic Viruses as Valets or Vandals?
Laura Evgin, Richard G. Vile · 2021 · Cancers
A Perspective of Immunotherapy for Prostate Cancer
Ida Silvestri, Susanna Cattarino, Sabrina Giantulli, Cristina Nazzari, Giulia Collalti, Alessandro Sciarra · 2016 · Cancers
High Endothelial Venule with Concomitant High CD8+ Tumor-Infiltrating Lymphocytes Is Associated with a Favorable Prognosis in Resected Gastric Cancer
Soon Auck Hong, Hye Won Hwang, Min Kyoon Kim, Tae Jin Lee, Kwangil Yim, Hye Sung Won, Der Sheng Sun, Eun Young Kim, Yoon Ho Ko · 2020 · Journal of Clinical Medicine
The role of active vaccination in cancer immunotherapy: lessons from clinical trials
Haydn Thomas Kissick, Martin George Sanda · 2015 · Current Opinion in Immunology
Pre-clinical development of gene modification of haematopoietic stem cells with chimeric antigen receptors for cancer immunotherapy
Sarah Marie Larson, Laurel Christine Truscott, Tzu‐Ting Chiou, Amie Patel, Roy L. Kao, Ang Andy Tu, Tulika Tyagi, Xiang Lü, David A. Elashoff, Satiro Nakamura De Oliveira · 2017 · Human Vaccines & Immunotherapeutics
Rationale for immunological approaches to breast cancer therapy
Gwennaëlle Monnot, Pedro J. Romero · 2017 · The Breast
Innovative Technologies in Nanomedicines: From Passive Targeting to Active Targeting/From Controlled Pharmacokinetics to Controlled Intracellular Pharmacokinetics
Yusuke Sato, Yu Sakurai, Kazuaki Kajimoto, Takashi Nakamura, Yuma Yamada, Hidetaka Akita, Hideyoshi Harashima · 2016 · Macromolecular Bioscience
Resistance to anticancer immunity in cancer patients: potential strategies to reverse resistance
Benjamin Bonavida, Salem Chouaı̈b · 2016 · Annals of Oncology
Adoptive cell therapy with tumour-infiltrating lymphocytes: the emerging importance of clonal neoantigen targets for next-generation products in non-small cell lung cancer
Jane D. Robertson, Max Salm, Markus Dangl · 2019 · Immuno-Oncology Technology
Cancer Immunotherapy: A Review
Anna Meiliana, Nurrani Mustika Dewi, Andi Wijaya · 2016 · The Indonesian Biomedical Journal